Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on the discrimination of durations: evidence for the involvement of 5-HT2A but not 5-HT3 receptors

Behavioural Pharmacology - Tập 16 Số 1 - Trang 43-51 - 2005
Karim Asgari1, S. Body1, J. F. Rickard2, Zhong-yuan ZHANG1, K.C.F. Fone1, C. M. Bradshaw1,3, E. Szabadi1
1Sponsorship: Supported by the BBSRC. ZZ was supported by a Wellcome Trust Travelling Fellowship.
2Jonathan Francis Rickard (1977–2003), a gifted and dedicated PhD student, made a major contribution to this work.
3requests for reprints to C.M. Bradshaw, Psychopharmacology Section, Division of Psychiatry, University of Nottingham, Room B109, Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Al-Ruwaitea, 1997, 517???570

Al-Zharani, 1996, Psychopharmacology (Berl), 127, 346???352

Barnes, 1999, Neuropharmacology, 38, 1083???1152, 10.1016/S0028-3908(99)00010-6

Baxter, 1995, Trends Pharmacol Sci, 16, 105???110

Body, 2001, Psychopharmacology (Berl), 158, 305???313

Body, 2002a, Pharmacol Biochem Behav, 71, 787???793, 10.1016/S0091-3057(01)00674-8

Body, 2002b, Behav Pharmacol, 13, 603???614, 10.1097/00008877-200212000-00001

Body, 2003, Behav Pharmacol, 14, 599???607, 10.1097/00008877-200312000-00004

Body, 2004a, Psychopharmacology (Berl), 176, 154???165, 10.1007/s00213-004-1871-1

Body, 2004b, J Psychopharmacol, 18, A42

Branchek, 1990, Mol Pharmacol, 38, 604

Chiang, 2000, Psychopharmacology (Berl), 151, 379???391, 10.1007/s002130000495

Costall, 1992, Pharmacol Toxicol, 70, 157???162, 10.1111/j.1600-0773.1992.tb00448.x

Fozard, 1984, Arch Pharmacol NS, 326, 36???44

Gibbon, 1997, Curr Opin Neurobiol, 7, 170???184, 10.1016/S0959-4388(97)80005-0

Glennon, 1989, Eur J Pharmacol, 168, 387???392, 10.1016/0014-2999(89)90802-9

Grondin, 2001, Psychol Bull, 127, 22???24, 10.1037/0033-2909.127.1.22

Higgins, 1992, Psychopharmacology (Berl), 106, 315???320

Higgins, 1993, J Pharmacol Exp Ther, 264, 1440???1449

Ho, 1998, J Psychopharmacol, 12, 68???78, 10.1177/026988119801200109

Ho, 2002, Pharmacol Biochem Behav, 71, 773???785, 10.1016/S0091-3057(01)00672-4

Hoyer, 1988, J Recept Res, 8, 59???81, 10.3109/10799898809048978

Hoyer, 2002, Pharmacol Biochem Behav, 71, 533???554, 10.1016/S0091-3057(01)00746-8

Killeen, 1988, Psychol Rev, 95, 274???295, 10.1037/0033-295X.95.2.274

Killeen, 1997, 79???131

Kilpatrick, 1990, Eur J Pharmacol, 182, 193???197, 10.1016/0014-2999(90)90513-6

Leysen, 1981, Life Sciences, 28, 1015???1022, 10.1016/0024-3205(81)90747-5

Matell, 2000, Bioessays, 22, 94???103, 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E

Mazzola-Pomietto, 1995, Psychopharmacology (Berl), 121, 488???493, 10.1007/BF02246499

Sharif, 1991, Br J Pharmacol, 102, 919???925, 10.1111/j.1476-5381.1991.tb12277.x

Stubbs, 1976, J Exp Anal Behav, 26, 15???25, 10.1901/jeab.1976.26-15

van Nueten, 1981, J Pharmacol Exp Ther, 218, 217???230

Zeiler, 1998, Behav Proc, 44, 89???99, 10.1016/S0376-6357(98)00042-4

Zgombick, 1995, Eur J Pharmacol (Mol Pharmacol Sect), 291, 9???15